A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma

NCT07464925 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma Multiforme of Brain
Glioma
Glioblastoma

Interventions

DRUG: GLIX1

Sponsor

Tetragon Biosciences Ltd